Follow-up Echocardiography of Atrial Septal Defect Device Closure

2015 ◽  
pp. 39-40
Author(s):  
Hakimeh Sadeghian ◽  
Zahra Savand-Roomi
Keyword(s):  
Atrial Septal Defect ◽  
Septal Defect ◽  
Device Closure

scholarly journals Is the Sac Waiting to Rupture? Sinus of Valsalva Aneurysm

Aorta ◽  
2016 ◽  
Vol 04 (03) ◽  
pp. 105-107 ◽  
Author(s):  
Ankur Phatarpekar ◽  
Milind Phadke ◽  
Charan Lanjewar ◽  
Prafulla Kerkar
Keyword(s):  
Atrial Septal Defect ◽  
Septal Defect ◽  
Sinus Of Valsalva ◽  
Device Closure ◽  
Sinus Of Valsalva Aneurysm ◽  
Lost To Follow Up

AbstractCompletely asymptomatic sinus of Valsalva aneurysms are rare entities, and there is no consensus regarding their management. We present the case of a patient who underwent atrial septal defect device closure at 5 years of age and was lost to follow-up, then presented 6 years later with unruptured sinus of Valsalva aneurysm and was closely followed. The aneurysm eventually ruptured and was successfully operated on with good outcomes.

scholarly journals Successful simultaneous transcatheter treatment for secundum atrial septal defect with valvular pulmonary stenosis in children under transthoracic echocardiography guidance

2021 ◽  
Author(s):  
Xuning Lu ◽  
Ping Wen ◽  
Yuhang Liu ◽  
Quanwei Zhu
Keyword(s):  
Atrial Septal Defect ◽  
Transthoracic Echocardiography ◽  
Septal Defect ◽  
Pulmonary Stenosis ◽  
Secundum Atrial Septal Defect ◽  
Device Closure ◽  
The Mean ◽  
Valvular Pulmonary Stenosis ◽  
Transcatheter Device

Abstract BACKGROUND Transcatheter device closure of secundum atrial septal defect (ASD) with valvular pulmonary stenosis (PS) under fluoroscopy and/or transesophageal echocardiography (TEE) guidance is a mature technology. However, little study has focused on whether the technology can be guided totally by transthoracic echocardiography (TTE), even in children.METHODS Thirteen children with ASD combined with PS underwent transcatheter device closure totally guided by TTE at our cardiac center from March 2 016 to August 2 019. Percutaneous transcatheter pulmonary valvuloplasty was performed first and then transcatheter closure of the ASD uneventfully.RESULTS All cases were successfully treated with transcatheter balloon pulmonary valvuloplasty and closure of ASD respectively via femoral vein approach solely under TTE guidance. The mean defect size was 8.1±1.4 mm (range: 5.5-10 mm), the preoperative mean pressure gradient across pulmonary valve was 61.2±5.5 mmHg (range: 51-71 mmHg). The mean device size used was 11.1±1.9 mm (range: 8- 14 mm), the mean procedure time was 55.1±8.0 min (range: 45-71 min). There were no serious cardiovascular related complications. During the follow-up period (10 mon to 47mon), no arrhythmias device, thrombosis, residual fistulas or device frame fractures were detected. PS gradient had significant difference before and after procedure during the follow up (t=28.9, P =0.000).CONCLUSION Simultaneous transcatheter treatment for ASD complicated by PS in children under TTE guidance is an safe and effective therapeutic option.

scholarly journals Transcatheter and intraoperative device closure of atrial septal defect in infants under three years of age

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Yangyang Han ◽  
Xiquan Zhang ◽  
Fengwei Zhang
Keyword(s):  
Atrial Septal Defect ◽  
Hospital Stay ◽  
Clinical Data ◽  
Septal Defect ◽  
Postoperative Hospital Stay ◽  
Device Closure ◽  
Young Infants ◽  
Group A ◽  
Group B

Abstract Background Transcatheter and intraoperative device closures have been widely used in the treatment of secundum atrial septal defect (ASD). However, for young infants with ASD, device closure remains controversial, and such treatment features limited data. We compared the clinical data and follow-up results of percutaneous and intraoperative device closure for ASD to evaluate the feasibility, safety, and efficacy of both treatments in infants under 3 years of age. Methods From September 2010 to September 2018, 186 children under 3 years of age with significant secundum ASD were included in this study. A total of 88 and 98 patients were divided into groups A (transcatheter device closure) and B (intraoperative device closure), respectively. The clinical data and follow-up results of the two groups were analyzed retrospectively. Result The mean age and weight of patients in group A were significantly higher than those in group B. The proportion of complex ASDs (multiples or rims deficiency) and the device/weight ratio in group B were significantly higher than those in group A. Successful closure was obtained in 86 (97.7%) and 96 (98.0%) infants in groups A and B, respectively, with two failed cases in each group (2.3% vs 2%). The rate of periprocedural complications reached 13.6 and 26.5% for groups A and B (P = 0.058), respectively. The durations of the procedure and postoperative hospital stay in group A were significantly shorter than those in group B (P < 0.05). Excellent follow-up results were observed in both groups. At present, no death nor major complications have occurred. Symptoms either resolved completely or improved significantly for all symptomatic infants. No residual shunts at the 6th month of follow-up evaluation were observed. Patients with failure to thrive gained weight appropriately for age, and the structure and hemodynamic parameters significantly improved during follow-up. Conclusion Transcatheter and intraoperative device closure are feasible, effective, and safe methods for the treatment of ASDs in infants under 3 years of age. Considering improved cosmetic effect and the short duration of the procedure and postoperative hospital stay, transcatheter is preferred for patients with appropriate conditions. Intraoperative device closure can be performed as an alternative to percutaneous closure, particularly for infants with large, complex ASDs, young age, or low-body weight.

scholarly journals Short, Intermediate and Long Term Follow up of Device Closure of Atrial Septal Defect (Secundum) Cases: Thirteen Years Experience with Special Reference to Complications

2015 ◽  
Vol 7 (2) ◽  
pp. 85-92
Author(s):  
Nurun Nahar Fatema
Keyword(s):  
Atrial Septal Defect ◽  
Special Reference ◽  
Aortic Regurgitation ◽  
Septal Defect ◽  
Study Patient ◽  
Device Closure ◽  
Residual Shunt ◽  
Long Term Follow Up

Background: Device closure of Atrial Septal Defect (ASD) Secundum type is gaining popularity because of short learning curve, cosmetic benefits, reduced hospital stay, reduced working hour loss, reduced pain, less or no need for general anesthesia etc. In most centers this is the first choice of therapy comparing to surgical closure. The major concern recently is related to development of erosion and aortic regurgitation. Objective of our study is to review the outcome of our cases over last 13 years with special reference to complication in our series and review from literatures. Methods: One thousand and twenty patients with secundum ASD with indication for closure, age 8 months to (median 11 years) 68 years from December 2000 to December 2013 were included in the study. Patient were followed up after device closure at 1, 3, 6, 9, 12, and 18 months and yearly thereafter with ECG, CXR, and Echocardiography. One hundred and seventy two cases were lost from follow up after first year. Results: Device was implanted on 1020 patient but tried on 1075 patient. Forty one cases postponed after balloon sizing and 12 for unstable position of device or mashrooming deformity of device. Immediate complications were ST changes (n=12), transient arrhythmia (n=4), residual shunt (n=7) etc. Immediate major complication was embolization of device (n=2). There was no late embolization, thromboembolic events, erosion, pericardial effusion, aortic regurgitation in follow up. Mean follow up time was 6.9 years (8 month to 13 years). Residual shunt was abolished in all patients other than those having another uncovered ASD (2 cases). Conclusion: Device closure of ASD is safe and effective in short, intermediate and long term follow up without any major late complication. DOI: http://dx.doi.org/10.3329/cardio.v7i2.22248 Cardiovasc. j. 2015; 7(2): 85-92

Early clinical experience with use of the ‘Amplatzer Septal Occluder’ device for atrial septal defect

1998 ◽  
Vol 8 (3) ◽  
pp. 295-302 ◽  
Author(s):  
James L Wilkinson ◽  
Tiow Hoe Goh
Keyword(s):  
Atrial Septal Defect ◽  
Septal Defect ◽  
Amplatzer Septal Occluder ◽  
Device Closure ◽  
Multiple Defects ◽  
Complete Closure ◽  
Septal Occluder Device ◽  
Occluder Device ◽  
The Right

AbstractDevice closure of oval fossa atrial scptal defects with the Amplatzer Septal Occluder was performed in 26 patients ranging in age from 0.89 to 60.44 years. In eight additional patients no device implant was performed because of the presence of multiple defects or because the defect was of a size unsuitable for closure with the devices currently available. The strectched diameter of the defects that were closed ranged from 4 to 23 mm (mean 14±5.4 mm) and device sizes ranged from 4 to 24 mm. Two devices were unstable, of which one embolized to the right atrium after release. Both devices were retrived at the same procedure. One of these parients subsequently underwent a successful device closure of his defect using a larger (24-mm) device. Three patients had multiple defects, which were successfully closed with a single device. At 1-month follow-up 23/26 (88%) and at 3-month follow-up 22/24 (92%) patients had complete closure of their defects, while two had residual shunts. One further patient who had complete closure of his defect at 1-month post-implant had his device removed and his atrial septal defect patched surgically 8 weeks after device closure. This was done as a result of the development of a vegetation affecting the device after an episode of septicaemia, which was not relate to the cardiac problems. There was no procedure-related morbidty or martality and all patients remain well at the present time.

scholarly journals Short-Term and Midterm Follow-Up of Transthoracic Device Closure of Atrial Septal Defect in Infants

2017 ◽  
Vol 104 (4) ◽  
pp. 1403-1409 ◽  
Author(s):  
Qiang Chen ◽  
Hua Cao ◽  
Gui-Can Zhang ◽  
Liang-wan Chen ◽  
Fan Xu ◽  
...  
Keyword(s):  
Atrial Septal Defect ◽  
Septal Defect ◽  
Device Closure ◽  
Short Term

scholarly journals Transcatheter Closure of Atrial Septal Defect with Amplatzer Device in Adolescence and Adults: Short Term Results: MCVTC Experience

2020 ◽  
Vol 5 (2) ◽  
Keyword(s):  
Atrial Septal Defect ◽  
Congenital Heart ◽  
Septal Defect ◽  
Transcatheter Closure ◽  
Heart Diseases ◽  
Device Closure ◽  
Short Term ◽  
Amplatzer Device ◽  
Invasive Cardiology

Introduction: Atrial septal defect (ASD) is one of the common congenital heart diseases accounting for 8% to 10% of total congenital heart disease at birth and one of the most common diseases in adulthood. Ostium Secundum (OS) ASD has been successfully closed surgically for over several decades. But even though the results are better, it is associated with discomfort, morbidity, and a thoracotomy scar. Transcatheter closure in these patients has advanced rapidly in recent years and represents a growing field in invasive cardiology. Methods: This prospective study was conducted at Manmohan cardiothoracic vascular and transplant center, Maharajgung, Kathmandu, Nepal. Fifty-two (52) patients with a diagnosis of OS ASD assessed for device closure. Patients underwent transthoracic and trans oesophageal echocardiography for the defect location, size, number, and associated anomalies. All patients with OS ASD fulfilling the inclusion criteria enrolled for device closure. The procedure conducted under fluoroscopy and transesophageal guidance. The cases were followed up at 3 and 6 months, reassessed clinically and by echocardiography for any complications. Results: The patients with ASD who enrolled in this study belonged to the age group of 14 to 63 years. The device closure attempted in 46 patients, and the remaining six patients excluded from the procedure due to unsuitable anatomy after GA guided TEE done. Among 46 patients, 44 (95%) had successful device closure. The mean age of the patient was 35.7+ 10 and 33 (71.7%) female, with 13 (28.3%) males. Conclusions: The transcatheter device closure of ASD in adolescents and adults has a high success rate with fewer complications and found to be safely documented during immediate and short term follow up. However, long terms follow up is required to conclude it.

scholarly journals Very late (>5 years) thrombus formation on an atrial septal defect device: a case report

2020 ◽  
Vol 8 (11) ◽  
pp. 4149
Author(s):  
Sudheer Venkata Bolinera ◽  
Srinivas Soma ◽  
Sanivarapu Srinivasa Reddy ◽  
Vijaya Pamidimukkala ◽  
Michael Naronha ◽  
...  
Keyword(s):  
Atrial Septal Defect ◽  
Septal Defect ◽  
Thrombus Formation ◽  
Device Closure ◽  
Atrial Septal Defect Closure ◽  
Septal Occluder Device ◽  
Occluder Device ◽  
History Of

Though percutaneous transcatheter atrial septal defect closure with newer generation occluder devices is a standard treatment at present, these devices have significant long-term risks (>1 year) associated with such as thrombus formation. Here, we present a case of 28 year-old patient presented with few symptoms and had a history of ASD device closure using amplatzer septal occluder device five years back. The patient was found to have a large thrombus (30×33 mm) attached to the device which was managed using anticoagulants and patients was advised for regular echocardiographic follow-up.

Sign in / Sign up

Export Citation Format

Share Document